These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 33388022)

  • 41. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.
    Faruqi J; Balasubramanyam A
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):167-179. PubMed ID: 36797835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19.
    Smith SM; Boppana A; Traupman JA; Unson E; Maddock DA; Chao K; Dobesh DP; Brufsky A; Connor RI
    J Med Virol; 2021 Jan; 93(1):409-415. PubMed ID: 32589756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.
    Kountouri A; Korakas E; Ikonomidis I; Raptis A; Tentolouris N; Dimitriadis G; Lambadiari V
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34065123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.
    Goyal A; Gupta Y; Kalaivani M; Praveen PA; Ambekar S; Tandon N
    Endocr Pract; 2022 Feb; 28(2):191-198. PubMed ID: 34920109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes mellitus in sub-saharan Africa during the COVID-19 pandemic: A scoping review.
    Sseguya W; Bahendeka S; MacLennan S; Mody N; Guntupalli AM
    PLoS One; 2024; 19(7):e0305112. PubMed ID: 38976666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unwinding Link between Coronavirus and Diabetes Patient.
    Bhadauria SS; Malviya R; Sharma PK
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1091-1110. PubMed ID: 35352656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crosstalk between SARS-CoV-2 Infection and Type II Diabetes.
    Azhar A; Khan WH; Al-Hosaini K; Zia Q; Kamal MA
    Comb Chem High Throughput Screen; 2022; 25(14):2429-2442. PubMed ID: 35293290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence.
    Sen S; Chakraborty R; Kalita P; Pathak MP
    World J Clin Cases; 2021 Oct; 9(28):8327-8339. PubMed ID: 34754842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pulmonary innate immune response in Sars-cov-2 infection].
    Bottino E; Ponce AA
    Rev Fac Cien Med Univ Nac Cordoba; 2022 Mar; 79(1):33-42. PubMed ID: 35312259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.
    Magdy Beshbishy A; Oti VB; Hussein DE; Rehan IF; Adeyemi OS; Rivero-Perez N; Zaragoza-Bastida A; Shah MA; Abouelezz K; Hetta HF; Cruz-Martins N; Batiha GE
    Front Public Health; 2021; 9():591982. PubMed ID: 34307267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System.
    Abdelmissih S
    Cureus; 2022 Oct; 14(10):e30788. PubMed ID: 36457603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
    Kloc M; Ghobrial RM; Lewicki S; Kubiak JZ
    J Diabetes Metab Disord; 2020 Dec; 19(2):2045-2048. PubMed ID: 33102261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail.
    Pal R; Bhasin MK; Bhadada SK
    Infect Disord Drug Targets; 2021; 21(5):e270421186842. PubMed ID: 33050869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 and diabetes mellitus: from pathophysiology to clinical management.
    Lim S; Bae JH; Kwon HS; Nauck MA
    Nat Rev Endocrinol; 2021 Jan; 17(1):11-30. PubMed ID: 33188364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
    Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
    J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.
    Memon SS; Biswas DA
    Cureus; 2022 Nov; 14(11):e31895. PubMed ID: 36579192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 and Obesity: "CoVesity"-a Pandemic Within a Pandemic.
    Zakka K; Chidambaram S; Mansour S; Mahawar K; Salminen P; Almino R; Schauer P; Kinross J; Purkayastha S;
    Obes Surg; 2021 Apr; 31(4):1745-1754. PubMed ID: 33479921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection.
    Dioguardi M; Cazzolla AP; Arena C; Sovereto D; Caloro GA; Dioguardi A; Crincoli V; Laino L; Troiano G; Lo Muzio L
    Pediatr Rep; 2021 Jul; 13(3):363-382. PubMed ID: 34287338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes and COVID-19; A Bidirectional Interplay.
    Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
    Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.